PLURISTEM THERAPEUTICS Chart calendar Pluristem Therapeutics
8d37b93682de22162e6456942ec9e8f7.vyfBLszijCihBLh9xVV1C0y-4lMIdphEkCgYTuMU-2Y.jR6MZZ_Q2WCRbss5sSRDaDmOiilbLOIw6X8qAqxtzkvbbJJLtbTjHJVx9Q~793ca1838526737c6eb323811bff8d41
Upcoming events on Pluristem Therapeutics
Past events on Pluristem Therapeutics
| 2024-04-09 | ATiO Conference |
| 2024-04-09 | MIW Germany Israel Technology Conference |
| 2024-03-31 | Reverse Split: 1 of 8 |
| 2024-03-27 | CISH Impact Investments Holdings Conference |
| 2024-03-20 10:40 am | Advanced Therapies Conference |
| 2024-03-19 09:40 am | Advanced Therapies Conference |
| 2024-03-17 | Bio Europe Spring Conference |
| 2024-01-19 09:00 am | Advanced Therapies Week Phacilitate Conference |
| 2023-12-11 | New England Venture Summit |
| 2023-11-12 | Q1 2024 Earnings Release |
| 2023-11-01 | The West Coast Family Office & High Net Worth Individuals Conference |
| 2023-09-12 12:00 am | H.C. Wainwright Global Investment Conference |
| 2022-11-17 | Challenges and Opportunities for Mesenchymal Stem Cells Conference |
| 2022-11-16 | Challenges and Opportunities for Mesenchymal Stem Cells Conference - Panelist |
| 2022-11-14 | Jefferies London Healthcare Conference |
| 2022-10-31 | CPHI Conference |
| 2022-07-14 09:00 am | Muscle Regeneration Phase III Topline Results Call |
| 2022-03-22 | Jewish National Fund USA Conference |
| 2022-02-06 | Interim 2022 Earnings Release |
| 2022-01-11 09:00 am | Business Update Call |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,05 0,05 0% | 0,02 0,02 50.03% | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -35,5 -38,1 6.83% | -29,5 -28,9 -1.87% | -50,6 -49,9 -1.39% | -41,6 -44,3 6.13% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -35,3 -37,8 6.62% | -29,2 -30,1 3.28% | -49,9 -49,1 -1.47% | 0,00 0,00 - |
|
Net income Million USD | Released Forecast Spread | -35,3 -37,8 6.62% | -29,2 -29,1 -0.28% | -49,9 -49,1 -1.47% | -41,2 -43,7 5.6% |
|
EPS USD | Released Forecast Spread | -23,2 -24,5 5.43% | -12,8 -12,9 0.93% | -14,2 -14,0 -1.14% | -10,2 -10,8 5.19% |
| Announcement Date | 12/09/19 | 10/09/20 | 13/09/21 | 21/09/22 |
Quarterly results
| Fiscal Period | June | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | ||||
|
EBIT Million USD | Released Forecast Spread | -10,8 -12,5 13.64% | -10,5 -13,5 22.41% | -8,88 -11,6 23.43% | ||
|
Net income Million USD | Released Forecast Spread | -10,9 -12,3 11.06% | -9,87 -13,3 25.83% | -9,01 -11,4 21.01% | -8,12 | |
|
EPS USD | Released Forecast Spread | -2,72 -3,04 10.53% | -2,48 -3,20 22.5% | -2,24 -2,80 20% | -1,52 -2,56 40.63% | -1,92 -2,56 25% |
| Announcement Date | 07/02/22 | 09/05/22 | 21/09/22 | 10/11/22 | 13/02/23 |
More events
